The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines

@article{Loder2012The2A,
  title={The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines},
  author={Elizabeth W. Loder and Rebecca C Burch and Paul B Rizzoli},
  journal={Headache: The Journal of Head and Face Pain},
  year={2012},
  volume={52}
}
BACKGROUND Updated guidelines for the preventive treatment of episodic migraine have been issued by the American Headache Society (AHS) and the American Academy of Neurology (AAN. [] Key Method We identified 2 additional recent guidelines for migraine prevention from the Canadian Headache Society and the European Federation of Neurological Societies.

Report of the Croatian Society for Neurovascular Disorders, Croatian Medical Association. Evidence based guidelines for treatment of primary headaches--2012 update.

TLDR
These guidelines have been developed to assist the physician in making appropriate choices in work-up and treatment of patients with headaches, based on a comprehensive review and meta-analysis of scientific evidence with regard to treatment possibilities in Croatia.

Preventive Treatment of Migraine

TLDR
Recently issued evidence‐based guidelines outline an array of pharmaceutical and complementary treatment choices with data establishing them as effective or probably effective for prevention of episodic or menstrually associated migraine.

Chronic headache treatment: can we always follow international guidelines?

TLDR
The current migraine and CTTH prevention guidelines and complexities that physicians encounter with their use are reviewed and a case series of treating chronic headache with a new multimodal antidepressant vortioxetine is included.

Revised French guidelines for the diagnosis and management of migraine in adults and children

TLDR
This article is a peer-reviewed and revised translation from French and for citations please use also the following reference of the original recommendations: Lanteri-Minet M, Valade D, Geraud G, Lucas C, Donnet A.

Guidelines for Neuropathic Pain Management in Patients with Cancer: A European Survey and Comparison

TLDR
The aim of this study was to assess the quality of the development and reporting of national clinical practice guidelines for neuropathic pain in several European countries.

Migraine overview and summary of current and emerging treatment options.

  • G. L. Peters
  • Medicine
    The American journal of managed care
  • 2019
TLDR
A new class of medication, calcitonin gene-related peptide (CGRP) antagonists, has been approved for migraine prevention in adults, and the newly approved CGRP antagonists are erenumab, fremanezumAB, and galcanezumab while eptinezumab looks to 2020 for approval.

Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018

TLDR
The spectrum of response to preventive therapy varies; in general, complete cessation of headaches is uncommon, although there are “super‐responders” to every therapy, as illustrated by patient reports of dramatic responses to treatment.

Vestibular Migraine: Treatment and Prognosis.

TLDR
Limited data indicate that the prognosis appears to be less favorable for vestibular migraine than for migraine headaches, and nonpharmacological measures including regular exercise, relaxation techniques, stress management, and biofeedback may be similar and can be combined with a pharmacological approach.

Update in migraine preventive treatment.

New advances in prevention of migraine

TLDR
Migraine’s abortive and prophylactic medications, based on their pharmacologic category, are reviewed, citing their recommended doses, efficacy, and side effects.
...

References

SHOWING 1-10 OF 43 REFERENCES

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

The 2012 AAN guideline “Evidence-based guideline update: NSAIDS and other complementary treatments for episodic migraine prevention in adults” has been retired by the AAN Board of Directors on

Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

In the article “Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy …

Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review)

TLDR
This practice parameter summarizes the results from the four evidence-based reviews on the management of patients with migraine: specifically, acute, preventive, and nonpharmacologic treatments for migraine, and the role of neuroimaging in patients with headache.

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

TLDR
Divalproex sodium, sodium valproate, topiramate, metoprolol, propranolol, and timolol are effective for migraine prevention and should be offered to patients with migraine to reduce migraine attack frequency and severity.

EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force

TLDR
Evidence-based or expert recommendations for the different drug treatment procedures in the particular migraine syndromes based on a literature search and the consensus of an expert panel are given.

Canadian Headache Society guideline for migraine prophylaxis.

TLDR
There is good evidence from randomized controlled trials for use of a number of different prophylactic medications in patients with migraine, and medication choice for an individual patient requires careful consideration of patient clinical features.

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults

TLDR
New evidence-based recommendations for the preventive treatment of migraine headache are provided and petasites (butterbur) is effective for migraine prevention and should be offered to patients with migraine to reduce the frequency of migraine attacks.

Patterns of Diagnosis and Acute and Preventive Treatment for Migraine in the United States: Results from the American Migraine Prevalence and Prevention Study

TLDR
The patterns of medical treatment for migraineurs in the United States are described to describe the patterns of treatment in the country.

[Evidence based guidelines for the treatment of primary headaches].

TLDR
The guidelines provide classification, diagnostic criteria and therapeutic principles for primary headaches, based on meta-analyses and recommendations from the world literature, with special reference to therapeutic options available in Croatia.

[Treatment guidelines for preventive treatment of migraine].

  • Medicine, Psychology
    Acta neurologica Taiwanica
  • 2008
TLDR
The Treatment Guideline Subcommittee of the Taiwan Headache Society evaluated the medications currently used for preventive therapy of migraine in Taiwan and proposed a Taiwan consensus about the major roles, recommended levels, clinical efficacy, adverse events and cautions of clinical practice for these medications in preventive treatment of migraine.